2026

– CDMO program advances to Stage 2 of development agreement valued at $1.125 million -Advancement of sustainable solution for the production of saffron, one of the world’s most valuable and health-promoting botanicals – In addition to future commercial manufacturing royalties, BioHarvest also holds a 25% ownership position in Saffron Composition   Vancouver, British Columbia and […]

Source plant is widely regarded as one of the most valuable fragrance raw materials in the world Stage 2 contract follows successful Stage 1 completion in March 2026 Vancouver, British Columbia and Rehovot, Israel— (May 12, 2026) – BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) (“BioHarvest” or the “Company”), a leader in Botanical Synthesis technology

Ilan Sobel joins Board of Directors with focused mandate on D2C growth.Dr. Zaki Rakib, Co-Founder and Executive Chairman, assumes role of Chief Executive Officer, Integrating R&D, Manufacturing, and Operations under the CDMO. Vancouver, British Columbia and Rehovot, Israel – April 29, 2026 – BioHarvest Sciences Inc. (Nasdaq: BHST) (FSE: 8MV0) (“BioHarvest” or the “Company”), a

CDMO division has successfully completed Stage 1 under a development contract Vancouver, British Columbia and Rehovot, Israel – March 31, 2026 — BioHarvest Sciences Inc. (“BioHarvest” or the “Company”), (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its CDMO division has successfully completed Stage 1

FY2025 Revenues were $34.5 million,  up 37% vs previous year. The VINIA brand has achieved the  No.1 resveratrol polyphenol position in the United States Market*. Successful 4Q2025 Institutional-led Financing raised gross proceeds of an oversubscribed  $19.9 million. Cash and cash equivalents of $23 million as of December 31, 2025. Vancouver, British Columbia and Rehovot, Israel